Members, on a voluntary basis, are from:
- Academia (i.e. clinicians and researchers)
- Advocacy (i.e. parents, patients and survivors)
- Industry, including clinicians, researchers and representatives from regulatory affairs
- Regulatory bodies, such as the European Medicine Agency and the Paediatric Committee, the Food and Drug Administration and national Competent Authorities.
- Any other stakeholders with interest in paediatric oncology drug development
Some of our members (see below):